Impact Biomedical (IBO) Operating Expenses (2022 - 2026)
Impact Biomedical (IBO) posted Operating Expenses of $2.3 million for Q1 2026, up 618.28% on a QoQ basis from -$443000.0 in Q4 2025, and up 127.33% year-over-year from $1.0 million in Q1 2025.
Impact Biomedical (IBO) Operating Expenses (2022 - 2026) Analysis & Trends
Impact Biomedical's Operating Expenses history runs 5 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Operating Expenses rose 127.33% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 million (down 86.28% YoY) and the FY2025 annual result came in at $312000.0, down 98.91% from the prior year.
- Operating Expenses was $2.3 million for Q1 2026 at Impact Biomedical, up from -$443000.0 in the prior quarter.
- Across five years, Operating Expenses topped out at $26.2 million in Q4 2024 and bottomed at -$443000.0 in Q4 2025.
- A 5-year average of $2.5 million and a median of $1.0 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses surged 2202.99% — and 2025, when it plunged 101.69%.
- Impact Biomedical's Operating Expenses stood at $1.0 million in 2022, then advanced by 10.37% to $1.1 million in 2023, then jumped by 2202.99% to $26.2 million in 2024, then slumped by 101.69% to -$443000.0 in 2025, then jumped by 618.28% to $2.3 million in 2026.
- Business Quant data shows IBO's Operating Expenses at $2.3 million in Q1 2026, -$443000.0 in Q4 2025, and $966000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 2.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | -443,000.00 |
| Sep 30, 2025 | 966,000.00 |
| Jun 30, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.01 Mn |
| Dec 31, 2024 | 26.23 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 626,000.00 |
| Mar 31, 2024 | 771,000.00 |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2023 | 803,000.00 |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 889,000.00 |
| Jun 30, 2022 | 800,000.00 |